Decision: Favourable
Study Title:
TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A Prospective, randomised-controlled, double-dummy, double-blind phase 3 multi-centre trial of TNK 0.25 mg/kg + placebo vs. ASA + placebo (2 arms with 1:1 block randomisation)
NREC Code:
22-NREC-CT-009
Decision:
Favourable
Meeting Date:
27/04/2022
Study Type:
CT application
Principal Investigator:
Prof. Beatrice Nolan
PI Institution:
CHI Crumlin
Sponsor:
Sanofi